Semaglutide, tirzepatide, and other GLP-1 drugs appear to slow alcohol absorption and blunt its intoxicating effects, ...
Adults with type 1 diabetes using one of three GLP-1-based medications had significantly greater reductions in body weight ...
A look at GLP-1 spend at medical aesthetics practices from 2021 to 2025, per data and analytics firm Guidepoint Qsight.
Conflicting studies on GLP-1 drugs’ vision impacts prompt calls for baseline eye exams and monitoring.
Tirzepatide treatment may lead to OSA remission or mild nonsymptomatic OSA in patients with moderate to severe OSA and obesity.
Needle-Free Compounded Semaglutide and Tirzepatide Tablets Offer Physician-Supervised, At-Home GLP-1 Treatment Access Through ...
Prosper Junior Bakiny has positions in Eli Lilly and Novo Nordisk. The Motley Fool recommends AstraZeneca Plc and Novo ...
The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted ...
MEDVi 2025 offers a doctor-led GLP-1 weight loss program with affordable compounded Semaglutide & Tirzepatide — safe, ...
The shortage of the diabetes and obesity injectable tirzepatide (Mounjaro, Zepbound) has been resolved, the FDA announced Thursday. As a result, compounders will have a grace period of 60 to 90 days ...
New guidance from the European Association for the Study of Obesity says that semaglutide or tirzepatide should be first-line ...
Efficacy of tirzepatide does not differ significantly between men and women, despite sex-specific differences in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback